How does Taltz work?
The active ingredient in Taltz, ixekizumab, is a monoclonal antibody that works by inhibiting the inflammatory response in adults with plaque psoriasis, active psoriatic arthritis, active ankylosing spondylitis, and non-radiographic axial spondyloarthritis.
Taltz selectively binds with interleukin 17A (IL-17A) cytokine, a naturally occurring substance that can cause inflammation. Taltz inhibits the release of pro-inflammatory cytokines and chemokines by inhibiting the interaction of IL-17A with the IL-17 receptor.
Taltz affects the immune system. It may increase the risk of infections, which can be serious. Taltz should not be used in patients who have any symptoms of infection, unless a doctor advises otherwise.
Read next
What are Monoclonal Antibodies and how do they work?
Monoclonal antibodies (mAbs) are man-made proteins that mimic the natural antibodies produced by our immune systems. Monoclonal antibodies can be formulated into medicines to treat various types of illnesses, such as cancer, rheumatoid arthritis or psoriasis.
Continue reading
What are IL-17 Inhibitors and how do they work?
IL-17 inhibitors are biologic drugs that block interleukin-17, a key protein that fuels inflammation in autoimmune diseases.
Continue reading
What are 6 key Taltz side effects to watch out for?
Common side effects of Taltz include injection site reactions, conjunctivitis, and nausea. More serious side effects include infections, inflammatory bowel disease, and severe allergic reactions. Continue reading
See also:
Related medical questions
- How does Taltz compare to Cosentyx for psoriatic arthritis?
- How long before Taltz works?
- Can I drink alcohol with Taltz?
- Is weight gain a side effect of Taltz?
- What are the new drugs for plaque psoriasis?
- What causes Plaque Psoriasis?
- How do you use the Taltz Autoinjector?
Drug information
Related support groups
- Taltz (11 questions, 16 members)
- Ixekizumab (6 questions, 4 members)